Objective  To analyze the research status, hotspots, and development trends of Callicarpa nudiflora base on bibiometric methods.

Methods  Using Callicarpa nudiflora as the search term, relevant Chinese and English literature published over the past two decades was retrieved from the China National Knowledge Infrastructure (CNKI) and Web of Science (WOS) core databases. Excel, CiteSpace, and VOSviewer were used to perform a visual analysis of the literature, including overall publication output, journal distribution, highly cited papers, collaboration networks, and keyword co-occurrence.

Results A total of 451 papers were included, comprising 397 Chinese and 54 English publications. The annual publication volume of Callicarpa nudiflora showed an overall upward trend. The leading author and institution were Gu Zhixin (Hainan Jiuzhitang Pharmaceutical Co., Ltd.), and China was the primary publishing country. The journals with the highest number of publications in Chinese and in English were Chinese Traditional and Herbal Drugs, and Phytochemistry, respectively. Highly cited papers in both languages mainly focused on chemical constituents, anti-inflammatory, antibacterial, hemostatic pharmacological effects, and mechanism studies. Research hotspots of Callicarpa nudiflora focused on active components, pharmacological effects and mechanisms, and clinical applications.

Conclusion Research on Callicarpa nudiflora has made certain progress domestically. International collaboration should be strengthened in the future, and its research trends may include deepening the studies on pharmacological effects and mechanisms, standardizing clinical trials, and developing new dosage forms.

1.中国药典2025年版. 一部[S]. 2025: 390.

2.李梦, 张小波, 景志贤, 等. 裸花紫珠分布区划研究[J]. 中国中药杂志, 2020, 45(15): 3642-3650. [Li M, Zhang XB, Jing ZX, et al. Comparative study on distribution of Callicarpa nudiflora by different regionalization methods[J]. China Journal of Chinese Materia Medica, 2020, 45(15): 3642-3650.] DOI: 10.19540/j.cnki.cjcmm.20200527.101.

3.康兴东, 叶阳. 裸花紫珠化学成分、药理活性及临床应用研究进展[J]. 特产研究, 2021, 43(4): 95-101. [Kang XD, Ye  Y. Research progress on chemical constituents, pharmacological effects and clinical applications of Callicarpa nudiflora[J]. Special Wild Economic Animal and Plant Research, 2021, 43(4): 95-101.] DOI: 10.16720/j.cnki.tcyj.2021.100.

4.Yu XL, Guo LF, Liu M, et al. Callicarpa nudiflora loaded on chitosan-collagen/organomontmorillonite composite membrane for antibacterial activity of wound dressing[J]. Int J Biol Macromol, 2018, 120(Pt B): 2279-2284. DOI: 10.1016/j.ijbiomac.2018.08.113.

5.Li YM, Yang YF, Kang XD, et al. Study on the anti-inflammatory effects of Callicarpa nudiflora based on the spectrum-effect relationship[J]. Front Pharmacol, 2022, 12: 806808. DOI: 10.3389/fphar.2021.806808.

6.杨颖, 邵骏菁, 周芹芹, 等. 基于抗H1N1活性和AHP-CRITIC混合加权法优选裸花紫珠提取工艺研究[J]. 中华中医药杂志, 2023, 38(5): 2084-2090. [Yang Y, Shao JJ, Zhou QQ, et al. Optimization of the extraction process of Callicarpa nudiflora based on anti-H1N1 activity and AHP-CRITIC mixed weighting method[J]. China Journal of Traditional Chinese Medicine and Pharmacy, 2023, 38(5): 2084-2090.] https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY202305024.htm.

7.Zhou ZQ, Wei XY, Fu HZ, et al. Chemical constituents of Callicarpa nudiflora and their anti-platelet aggregation activity[J]. Fitoterapia, 2013, 88: 91-95. DOI: 10.1016/j.fitote.2013.05.007.

8.沈刚, 龚普阳, 鄢红书, 等. 基于CiteSpace和VOSviewer可视化知识图谱的竹节参研究动态与热点分析[J]. 中草药, 2025, 56(13): 4752-4764. [Shen G, Gong PY, Yan HS, et al. Analysis of research trends and hotspots of Panacis Japonici Rhizoma based on CiteSpace and VOSviewer visual knowledge graph[J]. Chinese Traditional and Herbal Drugs, 2025, 56(13): 4752-4764.] DOI: 10.7501/j.issn.0253-2670.2025.13.019.

9.李志强, 刘建平, 王雪峰. 文献计量研究报告指南与清单的制定与展望[J]. 中国医学前沿杂志（电子版）, 2024, 16(10): 92-93. [Li ZQ, Liu JP, Wang XF. Development and prospect of bibliometrics research report guidelines and lists[J]. Chinese Journal of the Frontiers of Medical Science (Electronic Version), 2024, 16(10): 92-93.] https://www.cnki.com.cn/Article/CJFDTOTAL-YXQY202410015.htm.

10.Gao Y, Shi S, Ma W, et al. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer[J]. Int Immunopharmacol, 2019, 72: 374-384. DOI: 10.1016/j.intimp.2019.03.045.

11.陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能[J]. 科学研究, 2015, 33(2): 242-253. [Chen Y, Chen CM, Liu ZY, et al. The methodology function of CiteSpace mapping knowledge domains[J]. Scientific Research, 2015, 33(2): 242-253.] DOI: 10.16192/j.cnki.1003-2053.2015.02.009.

12.付健, 丁敬达. Citespace和VOSviewer软件的可视化原理比较[J]. 农业图书情报, 2019, 31(10): 31-37. [Fu J, Ding  JD. Comparison of visualization principles between Citespace and VOSviewer[J]. Journal of Library and Information Science in Agriculture, 2019, 31(10): 31-37.] DOI: 10.13998/j.cnki.issn1002-1248.2019.10.19-0776.

13.李仙仙, 邓清月, 和映玉, 等. 基于CiteSpace和VOSviewer可视化分析药食同源中药罗汉果的发展态势[J]. 中草药, 2023, 54(17): 5664-5676. [Li XX, Deng QY, He YY, et al. Visual analysis on development trend of medicine and food homologous traditional Chinese medicine Siraitia grosvenorii based on CiteSpace and VOSviewer[J]. Chinese Traditional and Herbal Drugs, 2023, 54(17): 5664-5676.] DOI: 10.7501/j.issn.0253-2670.2023.17.021.

14.王旭, 田艳花, 张楠, 等. 基于CiteSpace对中药青龙衣的研究现状及趋势进行可视化分析[J]. 药学前沿, 2025, 29(6): 1016-1024. [Wang X, Tian YH, Zhang N, et al. Visual analysis of the research status and trend of traditional Chinese medicine Qinglongyi based on CiteSpace[J]. Frontiers in Pharmaceutical Sciences, 2025, 29(6): 1016-1024.] DOI: 10.12173/j.issn.2097-4922.202411058.

15.莫干辉, 刘迪, 张莉娟, 等. 基于CiteSpace国内外百香果研究热点及发展趋势的可视化分析[J]. 广西科学, 2025, 32(1): 7-18. [Mo GH, Liu D, Zhang LJ, et al. Visual analysis of domestic and international research hotspots and trends on Passiflora edulis Sims based on CiteSpace[J]. Guangxi Sciences, 2025, 32(1): 7-18.] DOI: 10.13656/j.cnki.gxkx.20241231.002.

16.王祝年, 韩壮, 崔海滨, 等. 裸花紫珠的化学成分[J]. 热带亚热带植物学报, 2007, (4): 359-362. [Wang ZN, Han Z, Cui HB, et al. Chemical constituents from Callicarpa nudiflora[J]. Journal of Tropical and Subtropical Botany, 2007, (4): 359-362.] DOI: 10.3969/j.issn.1005-3395.2007.04.014.

17.梁纪军, 徐凯, 李留法, 等. 裸花紫珠总黄酮的抗炎、止血作用研究[J]. 现代中西医结合杂志, 2009, 18(26): 3161-3162. [Liang JJ, Xu K, Li LF, et al. Study of total flavonoids of Callicarpa nudiflora on anti-inflammatory and hemostasis effects[J]. Modern Journal of Integrated Traditional Chinese and Western Medicine, 2009, 18(26): 3161-3162.] DOI: 10.3969/j.issn.1008-8849.2009.26.010.

18.张洁, 李宝泉, 冯锋, 等. 裸花紫珠的化学成分及其止血活性研究[J]. 中国中药杂志, 2010, 35(24): 3297-3301. [Zhang  J, Li  BQ, Feng F, et al. Chemical constituents from Callicarpa nudiflora and their hemostatic acitivity[J]. China Journal of Chinese Materia Medica, 2010, 35(24): 3297-3301.] DOI: 10.4268/cjcmm20102415.

19.蔡金平, 董琳, 关薇薇, 等. 裸花紫珠的研究进展[J]. 现代药物与临床, 2012, 27(1): 60-64. [Cai JP, Dong L, Guan WW, et al. Research progress of Callicarpa nudiflora[J]. Drugs & Clinic, 2012, 27(1): 60-64.] https://d.wanfangdata.com.cn/periodical/CiBQZXJpb2RpY2FsQ0hJU29scjkyMDI2MDExMjE3MDQyNhITZ3d5eS16d3lmYzIwMTIwMTAxNBoIeGpyaGRpMm4%3D.

20.陈颖, 杨国才. 裸花紫珠抗炎作用及增强免疫功能的实验研究[J]. 广东微量元素科学, 2006, 13(8): 39-41. [Chen Y, Yang  GC. Study on the anti-inflammatory and immunologic effects of Callicarpa nudiflora Hook et Am[J]. Guangdong Trace Elements Science, 2006, 13(8): 39-41.] DOI: 10.3969/j.issn.1006-446X.2006.08.007.

21.冯世秀, 张旻, 易博, 等. 裸花紫珠化学成分与药理活性研究进展[J]. 中草药, 2017, 48(5): 1015-1026. [Feng SX, Zhang  M, Yi B, et al. Research progress on chemical constituents in Callicarpa nudiflora and their pharmacological activities[J], Chinese Traditional and Herbal Drugs, 2017, 48(5): 1015-1026.] DOI: 10.7501/j.issn.0253-2670.2017.05.028.

22.高飞鹏, 汪豪, 叶文才, 等. 裸花紫珠叶的化学成分[J]. 中国药科大学学报, 2010, 41(2): 120-123. [Gao FP, Wang H, Ye  WC, et al. Chemical constituents from the leaves of Callicarpa nudiflora[J]. Journal of China Pharmaceutical University, 2010, 41(2): 120-123.] https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYD201002008.htm.

23.马燕春, 张旻, 徐文彤, 等. 裸花紫珠化学成分及细胞毒活性研究[J]. 中国中药杂志, 2014, 39(16): 3094-3101. [Ma YC, Zhang M, Xu WT, et al. Chemical constituents from Callicarpa nudiflora and their cytotoxic activities[J]. China Journal of Chinese Materia Medica, 2014, 39(16): 3094-3101.] DOI: 10.4268/cjcmm20141618.

24.董琳, 刘明生, 王金辉. 裸花紫珠的脂溶性化学成分[J]. 中国药物化学杂志, 2009, 19(5): 371-374. [Dong L, Liu MS, Wang  JH. Lipophilic compounds of Callicarpa nudiflora Hook. et Arn.[J]. Chinese Journal of Medicinal Chemistry, 2009, 19(5): 371-374.] DOI: 10.14142/j.cnki.cn21-1313/r.2009.05.007.

25.董琳, 王金辉, 刘明生. 裸花紫珠叶中的酚酸类化学成分 [J]. 沈阳药科大学学报, 2010, 27(4): 290-291, 319. [Dong  L, Wang  JH, Liu MS. Phenolic acid constituents of leaves from Callicarpa nudiflora Hook.Et Arn.[J]. Journal of Shenyang Pharmaceutical University, 2010, 27(4): 290-291, 319.] DOI: 10.14066/j.cnki.cn21-1349/r.2010.04.010.

26.Yang Y, Li ZY, Shao JJ, et al. Callicarpa nudiflora Hook. & Arn.: a comprehensive review of its phytochemistry and pharmacology[J]. J Ethnopharmacol, 2021, 264: 113123. DOI: 10.1016/j.jep.2020.113123.

27.Luo YH, Zhou ZQ, Ma SC, et al. Three new antioxidant furofuran lignans from Callicarpa nudiflora[J]. Phytochem Lett, 2014, 7: 194-197. DOI: 10.1016/j.phytol.2013.12.001.

28.Mei WL, Han Z, Cui HB, et al. A new cytotoxic iridoid from Callicarpa nudiflora.[J]. Nat Prod Res, 2010, 24(10): 899-904. DOI: 10.1080/14786410802267544.

29.Sun X, Liu F, Yang X, et al. Seco-labdane diterpenoids from the leaves of Callicarpa nudiflora showing nitric oxide inhibitory activity[J]. Phytochemistry, 2018, 149: 31-41. DOI: 10.1016/j.phytochem.2018.02.001.

30.Feng SX, Yi B, Zhang M, et al. Iridoid glycosides from Callicarpa nudiflora Hook[J]. Nat Prod Res, 2017, 31(1/3): 181-189. DOI: 10.1080/14786419.2016.1224872.

31.Huang B, Fu HZ, Chen WK, et al. Hepatoprotective triterpenoid saponins from Callicarpa nudiflora[J]. Chem Pharm Bull (Tokyo), 2014, 62(7): 695-699. DOI: 10.1248/cpb.c14-00159.

32.Dong L, Zhang L, Zhang XP, et al. Two new 3,4-seco-labdane diterpenoids from Callicarpa nudiflora and their inhibitory activities against nitric oxide production[J]. Phytochem Lett, 2014, 10: 127-131. DOI: 10.1016/j.phytol.2014.08.014.

33.陈倩倩, 邹献亮, 侴桂新. 裸花紫珠的化学成分研究[J]. 中草药, 2023, 54(1): 15-28. [Chen QQ, Zou XL, Chou GX. Chemical constituents from Callicarpae nudiflorae Folium[J]. Chinese Traditional and Herbal Drugs, 2023, 54(1): 15-28.] DOI: 10.7501/j.issn.0253-2670.2023.01.003.

34.潘小琴, 肖辉, 尹强龙. 裸花紫珠胶囊联合西药治疗肝硬化上消化。道出血临床研究[J]. 新中医, 2022, 54(19): 101-104. [Pan XQ, Xiao H, Yin QL. Clinical study on Luohua Zizhu capsules combined with western medicine for upper gastrointestinal hemorrhage due to cirrhosis[J]. Journal of New Chinese Medicine, 2022, 54(19): 101-104.] DOI: 10.13457/j.cnki.jncm.2022.19.021.

35.李劲, 王之珺, 易博, 等. 裸花紫珠分散片联合米非司酮治疗围绝经期功能失调性子宫出血的疗效观察[J]. 中华中医药学刊, 2022, 40(10): 224-226. [Li J, Wang ZJ, Yi B, et al. Therapeutic effect of Callicarpa nudiflora dispersible tablets combined with mifepristone on dysfunctional uterine bleeding in perimenopause[J]. Chinese Archives of Traditional Chinese Medicine, 2022, 40(10): 224-226.] DOI: 10.13193/j.issn.1673-7717.2022.10.052.

36.鲍军, 王宇, 郭庆涛, 等. 裸花紫珠颗粒联合西咪替丁治疗上消化道出血的疗效观察[J]. 现代药物与临床, 2024, 39(12): 3145-3149. [Bao J, Wang Y, Guo QT, et al. Clinical observation of Luohuazizhu granules combined with cimetidine in treatment of upper gastrointestinal bleeding[J]. Drugs & Clinic, 2024, 39(12): 3145-3149.] https://www.cnki.com.cn/Article/CJFDTOTAL-GWZW202412016.htm.

37.涂绍军. 裸花紫珠颗粒辅治肺咯血的临床效果及对凝血功能与炎性因子水平的影响[J]. 临床合理用药, 2024, 17(17): 47-50. [Tu SJ. Clinical effect of Luohua Zizhu granules on pulmonary hemoptysis and its effect on coagulation function and inflammatory factor levels[J]. Chinese Journal of Clinical Rational Drug Use, 2024, 17(17): 47-50.] DOI: 10.15887/j.cnki.13-1389/r.2024.17.013.

38.邹东东, 郑红艳. 中成药裸花紫珠片治疗肛肠病术后出血的临床效果[J]. 临床合理用药杂志, 2021, 14(32): 92-94. [Zou  DD, Zheng HY. Clinical effect of Luohua Zizhu tablets in the treatment of postoperative hemorrhage of anorectal diseases[J]. Chinese Journal of Clinical Rational Drug Use, 2021, 14(32): 92-94.] DOI: 10.15887/j.cnki.13-1389/r.2021.32.036.

39.郭闪闪, 韩红霞. 裸花紫珠颗粒治疗小儿细菌性上呼吸道感染临床疗效观察[J]. 黑龙江医药, 2019, 32(5): 1059-1061.[Guo SS, Han HX. Observation on the clinical efficacy of Luohua Zizhu granules in the treatment of bacterial upper respiratory tract infection in children[J]. Heilongjiang Medicine Journal, 2019, 32(5): 1059-1061.] DOI: 10.14035/j.cnki.hljyy.2019.05.024.

40.过云, 孙浩博, 虞俊杰. 裸花紫珠颗粒联合磺胺嘧啶银对四肢深Ⅱ度烧伤患者的临床疗效[J]. 中成药, 2024, 46(11): 3888-3891. [Guo Y, Sun HB, Yu JJ. Clinical efficacy of Luohua Zizhu granules combined with silver sulfadiazine in the treatment of patients with deep second-degree burns of limbs[J]. Chinese Traditional Patent Medicine, 2024, 46(11): 3888-3891.] DOI: 10.3969/j.issn.1001-1528.2024.11.061.

41.王紫璇, 薛晓鸥, 孙璐. 裸花紫珠治疗慢性盆腔炎的网络药理学研究[J]. 黑龙江医学, 2021, 45(17): 1837-1842. [Wang  ZX, Xue XO, Sun L. Network pharmacology study on the treatment of chronic pelvic inflammatory disease by Callicarpa nudiflora particle[J]. Heilong Medical Journal, 2021, 45(17): 1837-1842.] DOI: 10.3969/j.issn.1004-5775.2021.17.016.

42.王一新, 李慧, 郭敏, 等. 裸花紫珠颗粒佐治急性扁桃体炎疗效观察[J]. 微量元素与健康研究, 2020, 37(1): 19, 22. [Wang  YX, Li H, Guo M, et al. Observation on the efficacy of Luohua Zizhu granules in the treatment of acute tonsillitis[J]. Studies of Trace Elements and Health, 2020, 37(1): 19, 22.] https://www.cnki.com.cn/Article/CJFDTOTAL-WYJK202001011.htm.

43.张欢, 孙冰, 于雪莹, 等. 裸花紫珠颗粒联合糠酸莫米松治疗变应性鼻炎的临床研究[J]. 现代药物与临床, 2025, 40(7): 1732-1736. [Zhang H, Sun B, Yu XY, et al. Clinical study on Luohua Zizhu granules combined with mometasone furoate aqueous in treatment of allergic rhinitis[J]. Drugs & Clinic, 2025, 40(7): 1732-1736.] DOI: 10.7501/j.issn.1674-5515.2025.07.020.

44.Fu HZ, Ma YY, Ma SC, et al. Two new iridoid glycosides from Callicarpa nudiflora[J]. J Asian Nat Prod Res, 2020, 22(3): 264-270. DOI: 10.1080/10286020.2018.1557636.

45.Zhan LL, Huang WM, Bian YT, et al. A new labdane-type diterpenoids from Callicarpa nudiflora[J]. China J Chin Mater Med, 2021, 46(16): 4139-4144. DOI: 10.19540/j.cnki.cjcmm.20210429.202.

46.Fan MH, Du TT, Liu XY, et al. Isolation and identification of monoterpenoids from Callicarpa nudiflora[J]. Chem Biodivers, 2024, 21(12): e202401475. DOI: 10.1002/cbdv.202401475.

47.Dong L, Zhang XP, Liu MS, et al. Two new ent-3,4-seco-labdane diterpenoids from Callicarpa nudiflora[J]. J Asian Nat Prod Res, 2013, 15(1): 30-34. DOI: 10.1080/10286020.2012.742509.

48.何艳, 胡小祥, 胡雯婷, 等. HPLC同时测定裸花紫珠系列制剂中6种成分的含量[J]. 中国现代应用药学, 2021, 38(22): 2815-2819. [He Y, Hu XX, Hu WT, et al. Simultaneous determination of 6 Constituents in Luohua Zizhu Series preparations by HPLC[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(22): 2815-2819.] DOI: 10.13748/j.cnki.issn1007-7693.2021.22.009.

49.吉艺宽, 邹导夫, 李少方, 等. 中兽药裸花紫珠颗粒抗菌、抗炎及抗氧化活性研究[J]. 黑龙江畜牧兽医, 2023, (11): 116-120. [Ji YK, Zou DF, Li SF, et al. Study on antibacterial, anti-inflammatory and antioxidant activity of Chinese veterinary drug Callicarpa nudiflora granules[J]. Heilongjiang Animal Science and Veterinary Medicine, 2023, (11): 116-120.] DOI: 10.13881/j.cnki.hljxmsy.2022.09.0172.

50.Liu TC, Wang RQ, Liu CP, et al. Active substances from Callicarpa nudiflora exert anti-cervicitis effects and regulate NLRP3-associated inflammation[J]. Molecules, 2021, 26(20): 6217. DOI: 10.3390/molecules26206217.

51.Nong KY, Qin XY, Liu ZN, et al. Potential effects and mechanism of flavonoids extract of Callicarpa nudiflora Hook on DSS-induced colitis in mice[J]. Phytomedicine, 2024, 128: 155523. DOI: 10.1016/j.phymed.2024.155523.

52.Luo YH, Fu HZ, Huang B, et al. Hepatoprotective iridoid glucosides from Callicarpa nudiflora[J]. J Asian Nat Prod Res, 2016, 18(3): 274-279. DOI: 10.1080/10286020.2015.1074572.

53.李吉庆, 林道斌, 张永杰, 等. 裸花紫珠调控IGF-1/PI3K/Akt信号通路对糖尿病足溃疡大鼠创面愈合的影响[J]. 中国老年学杂志, 2023, 43(6): 1458-1462. [Li JQ, Lin DB, Zhang YJ, et al. Effect of Callicarpa nudiflora regulating IGF-1/PI3K/Akt signaling pathway on wound healing in diabetic foot ulcer rats[J]. Chinese Journal of Gerontology, 2023, 43(6): 1458-1462.] DOI: 10.3969/j.issn.1005-9202.2023.06.044.